Coverage for Restasis will require a review for every claim, and each authorization will allow coverage for five years. For more information, visit http://www.shpnc.org/pharm-restasis.html, or visit the Plan website, http://www.shpnc.org.
State Health Plan Announces Coverage Change for Restasis®
The State Health Plan (SHP) has announced that beginning January 3, 2011, Restatis® (cyclosporine ophthalmic emulsion) will be moved to the $55 copay tier—from the current $35 copay tier—and will require a coverage review. The Plan says the change will help to ensure appropriate use of the medication and help to maintain an affordable prescription drug benefit.
More Posts in Bulletins
Share this Post